on February 17, 2005
Published online before print February 17, 2005, doi: 10.1161/01.ATV.0000159519.07181.33
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 7, 2004
Accepted on February 2, 2005
Role of Caspases in Death and Survival of the Plaque Macrophage
Thomas Q. Nhan ;
From the Departments of Pathology (T.Q.N., W.C.L., S.M.S.) and Medicine (W.C.L.), University of Washington, Seattle, Wash.
* To whom correspondence should be addressed. E-mail: steves{at}u.washington.edu.
Abstract--This review considers the role of macrophage cell death in formation of the necrotic core and in plaque progression, and lists many of the possible mediators of macrophage cell death. Among these, perhaps the most cited toxic agent is oxidized low-density lipoprotein (oxLDL). Whereas oxLDL can kill macrophage, and whereas the form of death is morphologically apoptotic, caspase inhibitors appear to be ineffective in preventing death. This finding is consistent with recent literature showing how the canonical caspase pathways are used for physiological cellular functions other than cell death. Plaque macrophages appear to be among the cells with this nonapoptotic signaling function for activated caspases. In many of the other cell types, caspase activation appears to play a critical role in cell differentiation. We discuss possible functions of plaque macrophage using the nondeath caspase pathway. Recent literature shows that physiological and developmental functions of many cell types require active caspases without progressing to cell death. We discuss the role of macrophage cell death in plaque progression, possible mediators of macrophage cell death, and the possible functions of plaque macrophage using the nondeath caspase pathway.
Key words: apoptosis • caspase • death receptors • monocyte/macrophage • plaque rupture
This article has been cited by other articles:
 |
|
 |
|
  L. S. Chiapello, J. L. Baronetti, A. P. Garro, M. F. Spesso, and D. T. Masih Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway Int. Immunol., December 1, 2008; 20(12): 1527 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wehinger, I. Tancevski, W. Schgoer, P. Eller, K. Hochegger, M. Morak, A. Hermetter, A. Ritsch, J. R. Patsch, and B. Foeger Phospholipid Transfer Protein Augments Apoptosis in THP-1-Derived Macrophages Induced by Lipolyzed Hypertriglyceridemic Plasma Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 908 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Namgaladze and B. Brune Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2510 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Q. Nhan, W. C. Liles, and S. M. Schwartz Physiological Functions of Caspases Beyond Cell Death Am. J. Pathol., September 1, 2006; 169(3): 729 - 737. [Full Text] [PDF]
|
|
|
|
|
|
A. Boullier, Y. Li, O. Quehenberger, W. Palinski, I. Tabas, J. L. Witztum, and Y. I. Miller Minimally Oxidized LDL Offsets the Apoptotic Effects of Extensively Oxidized LDL and Free Cholesterol in Macrophages Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1169 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tabas Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis: The Importance of Lesion Stage and Phagocytic Efficiency Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2255 - 2264. [Abstract] [Full Text] [PDF]
|
|